Stephen E Gitelman

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Nephrogenic syndrome of inappropriate antidiuresis: a novel disorder in water balance in pediatric patients
    Stephen E Gitelman
    Department of Pediatrics, Division of Pediatric Endocrinology, University of California at San Francisco, San Francisco, California 94143, USA
    Am J Med 119:S54-8. 2006
  2. ncbi Nephrogenic syndrome of inappropriate antidiuresis
    Brian J Feldman
    Department of Pediatrics, Division of Endocrinology, University of California at San Francisco, San Francisco, CA 94143, USA
    N Engl J Med 352:1884-90. 2005
  3. ncbi Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children
    Eric A Huang
    Department of Pediatrics, Division of Endocrinology, University of California, San Francisco School of Medicine, USA
    J Pediatr 148:128-31. 2006
  4. ncbi Increased incidence in post-transplant diabetes mellitus in children: a case-control analysis
    Louise C Greenspan
    Division of Endocrinology, Department of Pediatrics, University of California, San Francisco, CA 94143 0434, USA
    Pediatr Nephrol 17:1-5. 2002
  5. ncbi Congenital hyperinsulinism in an infant caused by a macroscopic insulin-producing lesion
    Andrew A Bremer
    Department of Pediatrics, Division of Endocrinology, University of California, San Francisco 94143 0434, USA
    J Pediatr Endocrinol Metab 20:437-40. 2007
  6. ncbi Prevalence and characteristics of type 2 diabetes mellitus in 9-18 year-old children with diabetic ketoacidosis
    Anil Sapru
    Pediatric Critical Care Medicine, University of California, San Francisco, CA 94143, USA
    J Pediatr Endocrinol Metab 18:865-72. 2005
  7. ncbi The effect of oral alpha-lipoic acid on oxidative stress in adolescents with type 1 diabetes mellitus
    Eric A Huang
    Division of Endocrinology, Department of Pediatrics, University of California, San Francisco School of Medicine, San Francisco, CA 94143 0434, USA
    Pediatr Diabetes 9:69-73. 2008
  8. ncbi Persistent elevation of urine aquaporin-2 during water loading in a child with nephrogenic syndrome of inappropriate antidiuresis (NSIAD) caused by a R137L mutation in the V2 vasopressin receptor
    CLEMENT C CHEUNG
    Department of Pediatrics, Division of Endocrinology, University of California, San Francisco, San Francisco, CA 94143
    Int J Pediatr Endocrinol 2012:3. 2012
  9. ncbi The use of a continuous glucose monitoring system in hypoglycemic disorders
    Susan C Conrad
    Department of Pediatrics, University of California at San Francisco, San Francisco 94143, USA
    J Pediatr Endocrinol Metab 17:281-8. 2004
  10. ncbi A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes
    Kevan C Herold
    Associate Professor of Medicine, Columbia University, PH10 105, 630 W 168th St, New York, NY 10032, USA
    Diabetes 54:1763-9. 2005

Collaborators

Detail Information

Publications15

  1. ncbi Nephrogenic syndrome of inappropriate antidiuresis: a novel disorder in water balance in pediatric patients
    Stephen E Gitelman
    Department of Pediatrics, Division of Pediatric Endocrinology, University of California at San Francisco, San Francisco, California 94143, USA
    Am J Med 119:S54-8. 2006
    ..including the following: (1) What is the frequency? (2) Are there nonrenal manifestations? (3) Are heterozygotes affected? (4) What is the optimal therapy? and (5) How do these mutations cause constitutive activation of the receptor?..
  2. ncbi Nephrogenic syndrome of inappropriate antidiuresis
    Brian J Feldman
    Department of Pediatrics, Division of Endocrinology, University of California at San Francisco, San Francisco, CA 94143, USA
    N Engl J Med 352:1884-90. 2005
    ..These novel mutations cause constitutive activation of the receptor and are the likely cause of the patients' SIADH-like clinical picture, which we have termed "nephrogenic syndrome of inappropriate antidiuresis."..
  3. ncbi Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children
    Eric A Huang
    Department of Pediatrics, Division of Endocrinology, University of California, San Francisco School of Medicine, USA
    J Pediatr 148:128-31. 2006
    ..Fluid intake was liberalized after serum sodium normalization. All four children normalized their serum sodium. No side effects or toxicities were experienced. Oral urea is a safe, effective treatment for chronic SIAD in children...
  4. ncbi Increased incidence in post-transplant diabetes mellitus in children: a case-control analysis
    Louise C Greenspan
    Division of Endocrinology, Department of Pediatrics, University of California, San Francisco, CA 94143 0434, USA
    Pediatr Nephrol 17:1-5. 2002
    ..We suggest that all children undergoing renal transplantation be screened routinely for PTDM after transplantation, and that such patients may benefit from the avoidance of tacrolimus, as it may cause permanent beta-cell injury...
  5. ncbi Congenital hyperinsulinism in an infant caused by a macroscopic insulin-producing lesion
    Andrew A Bremer
    Department of Pediatrics, Division of Endocrinology, University of California, San Francisco 94143 0434, USA
    J Pediatr Endocrinol Metab 20:437-40. 2007
    ..We describe a 1 month-old infant with severe congenital hyperinsulinism who had a macroscopic insulin-producing pancreatic lesion successfully treated with focal lesion enucleation...
  6. ncbi Prevalence and characteristics of type 2 diabetes mellitus in 9-18 year-old children with diabetic ketoacidosis
    Anil Sapru
    Pediatric Critical Care Medicine, University of California, San Francisco, CA 94143, USA
    J Pediatr Endocrinol Metab 18:865-72. 2005
    ..To estimate the prevalence of type 2 diabetes mellitus (DM2) in 9-18 year-old children with diabetic ketoacidosis (DKA) and to describe the presenting biochemical characteristics and response to standardized DKA treatment...
  7. ncbi The effect of oral alpha-lipoic acid on oxidative stress in adolescents with type 1 diabetes mellitus
    Eric A Huang
    Division of Endocrinology, Department of Pediatrics, University of California, San Francisco School of Medicine, San Francisco, CA 94143 0434, USA
    Pediatr Diabetes 9:69-73. 2008
    ..Recently, an oral controlled-release formulation of alpha-lipoic acid (CRLA) was developed, and a pharmacokinetic study demonstrated that CRLA maintained significant plasma levels for 67% longer than a common quick-release formulation...
  8. ncbi Persistent elevation of urine aquaporin-2 during water loading in a child with nephrogenic syndrome of inappropriate antidiuresis (NSIAD) caused by a R137L mutation in the V2 vasopressin receptor
    CLEMENT C CHEUNG
    Department of Pediatrics, Division of Endocrinology, University of California, San Francisco, San Francisco, CA 94143
    Int J Pediatr Endocrinol 2012:3. 2012
    ..In addition, this is the first longitudinal report of a pediatric patient with NSIAD diagnosed in infancy who demonstrates the ability to maintain eunatremia during ad lib dietary intake...
  9. ncbi The use of a continuous glucose monitoring system in hypoglycemic disorders
    Susan C Conrad
    Department of Pediatrics, University of California at San Francisco, San Francisco 94143, USA
    J Pediatr Endocrinol Metab 17:281-8. 2004
    ..1% and 93.2%, respectively. CONCLUSION: CGMS is a useful adjunct in the diagnosis and evaluation of hypoglycemia, and for documentation of euglycemia in these patients following therapy...
  10. ncbi A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes
    Kevan C Herold
    Associate Professor of Medicine, Columbia University, PH10 105, 630 W 168th St, New York, NY 10032, USA
    Diabetes 54:1763-9. 2005
    ....
  11. ncbi Nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a paradigm for activating mutations causing endocrine dysfunction
    Stephen M Rosenthal
    University of California, San Francisco
    Pediatr Endocrinol Rev 4:66-70. 2006
    ..The mechanisms by which these mutations constitutively activate the V2R are currently being investigated...
  12. ncbi A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes
    Darrell M Wilson
    Division of Pediatric Endocrinology and Diabetes, Stanford University, Stanford, California 94305 5208, USA
    Diabetes Care 28:15-9. 2005
    ....
  13. ncbi Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
    Kevan C Herold
    Naomi Berrie Diabetes Center and the Department of Medicine, Division of Endocrinology, College of Physicians and Surgeons, Columbia University, New York 10032, USA
    N Engl J Med 346:1692-8. 2002
    ..Preclinical studies suggested that a monoclonal antibody against CD3 could reverse hyperglycemia at presentation and induce tolerance to recurrent disease...
  14. ncbi Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study
    Vicki Seyfert-Margolis
    Immune Teolerance Network, Bethesda, Maryland, USA
    Diabetes 55:2588-94. 2006
    ..They may be useful for assessment of cellular autoimmune responses involved in type 1 diabetes...
  15. ncbi Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus
    Susan C Conrad
    University of California, San Francisco 94143, USA
    J Pediatr 140:235-40. 2002
    ..The basal rate comprises 40% to 45% of the total daily insulin dose, and the timing of maximum basal rates is likely to occur in the late evening hours in prepubertal children...